Purpose <p>To evaluate the association between hemodynamic depression (HD) during CAS and major adverse cardiovascular events (MACE).</p> Methods <p>We systematically searched four major databases for studies reporting the HD and MACE during CAS. The risk of bias in the included studies was assessed using a modified version of Newcastle–Ottawa scale. The heterogeneity between the studies was evaluated based on the <i>I</i><sup>2</sup> statistic and Dixon’s Q‐test. We assessed heterogeneity using the <i>I</i><sup>2</sup> statistic. A fixed-effect model was used if <i>I</i><sup>2</sup> &lt; 50%; otherwise, a random-effects model was applied. Results were reported as ORs with 95% CIs. Funnel plots and Egger’s test were used to evaluate the publication bias.</p> Results <p>Fourteen studies comprising 4418 patients were included in the meta-analysis. Evidence of low certainty indicated that the occurrence of HD was significantly associated with an increased risk of stroke (OR 2.12, 95% CI 1.4–3.22, <i>I</i><sup>2</sup> = 0), transient ischemic attack (TIA) (OR 2.72, 95% CI 1.51–4.88, <i>I</i><sup>2</sup> = 41.2), and all-cause mortality (OR 2.81, 95% CI 1.22–6.44, <i>I</i><sup>2</sup> = 0). However, very low-certainty evidence suggested no significant association between HD and myocardial infarction (MI) (OR 1.49, 95% CI 0.61–3.61, <i>I</i><sup>2</sup> = 0).</p> Conclusions <p>HD during CAS is significantly associated with a risk of TIA, stroke, and all-cause mortality, but not with the risk of MI.</p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Impact of Periprocedural Hemodynamic Depression on Outcomes After Carotid Artery Stenting: A Systematic Review and Meta-Analysis

  • Xin Liu,
  • Xiaowei Liu,
  • Yunsen Zhang,
  • Yi Zheng,
  • Keyu Chen,
  • Zhao Zhang,
  • Yubin Tang,
  • Xuejun Xu

摘要

Purpose

To evaluate the association between hemodynamic depression (HD) during CAS and major adverse cardiovascular events (MACE).

Methods

We systematically searched four major databases for studies reporting the HD and MACE during CAS. The risk of bias in the included studies was assessed using a modified version of Newcastle–Ottawa scale. The heterogeneity between the studies was evaluated based on the I2 statistic and Dixon’s Q‐test. We assessed heterogeneity using the I2 statistic. A fixed-effect model was used if I2 < 50%; otherwise, a random-effects model was applied. Results were reported as ORs with 95% CIs. Funnel plots and Egger’s test were used to evaluate the publication bias.

Results

Fourteen studies comprising 4418 patients were included in the meta-analysis. Evidence of low certainty indicated that the occurrence of HD was significantly associated with an increased risk of stroke (OR 2.12, 95% CI 1.4–3.22, I2 = 0), transient ischemic attack (TIA) (OR 2.72, 95% CI 1.51–4.88, I2 = 41.2), and all-cause mortality (OR 2.81, 95% CI 1.22–6.44, I2 = 0). However, very low-certainty evidence suggested no significant association between HD and myocardial infarction (MI) (OR 1.49, 95% CI 0.61–3.61, I2 = 0).

Conclusions

HD during CAS is significantly associated with a risk of TIA, stroke, and all-cause mortality, but not with the risk of MI.

Graphical Abstract